Considerations in the management of patients with philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)1512-1516
Number of pages5
JournalJournal of Clinical Oncology
Volume29
Issue number12
DOIs
StatePublished - Apr 20 2011
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{b563a4e4593d4bda97d2098ca96a3d16,
title = "Considerations in the management of patients with philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy",
author = "Hagop Kantarjian and Jorge Cortes",
year = "2011",
month = "4",
day = "20",
doi = "10.1200/JCO.2010.33.9176",
language = "English (US)",
volume = "29",
pages = "1512--1516",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "12",

}

TY - JOUR

T1 - Considerations in the management of patients with philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

AU - Kantarjian, Hagop

AU - Cortes, Jorge

PY - 2011/4/20

Y1 - 2011/4/20

UR - http://www.scopus.com/inward/record.url?scp=79954986886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954986886&partnerID=8YFLogxK

U2 - 10.1200/JCO.2010.33.9176

DO - 10.1200/JCO.2010.33.9176

M3 - Comment/debate

C2 - 21422414

AN - SCOPUS:79954986886

VL - 29

SP - 1512

EP - 1516

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 12

ER -